Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Osteoporosis, a disease endemic in Western society,
typically reflects an imbalance in skeletal turnover so that bone
resorptionexceeds bone formation. Bone resorption is the unique
functionof the osteoclast, and anti-osteoporosis therapy to date has
targetedthis cell. The osteoclast is a specialized macrophage
polykaryonwhose differentiation is principally regulated by macrophage
colony-stimulatingfactor, RANK ligand, and osteoprotegerin. Reflecting
integrin-mediatedsignals, the osteoclast develops a specialized
cytoskeleton thatpermits it to establish an isolated microenvironment
between itselfand bone, wherein matrix degradation occurs by a process
involvingproton transport. Osteopetrotic mutants have provided a
wealthof information about the genes that regulate the differentiationof osteoclasts and their capacity to resorb bone.
Department of Pathology, Washington University School of
Medicine, Barnes-Jewish Hospital North, Mailstop 90-31-649, 216 South
Kingshighway, St. Louis, MO 63110, USA. E-mail:
teitelbs{at}medicine.wustl.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
INTRODUCTION TO SPECIAL ISSUE
Paula Kiberstis, Orla Smith, and Colin Norman (1 September 2000) Science289 (5484), 1497.
[DOI: 10.1126/science.289.5484.1497] |Summary »
NEWS
Robert F. Service (1 September 2000) Science289 (5484), 1498.
[DOI: 10.1126/science.289.5484.1498] |Summary »|Full Text »
REVIEW
Patricia Ducy, Thorsten Schinke, and Gerard Karsenty (1 September 2000) Science289 (5484), 1501.
[DOI: 10.1126/science.289.5484.1501] |Abstract »|Full Text »|PDF »
REVIEW
Gideon A. Rodan and T. John Martin (1 September 2000) Science289 (5484), 1508.
[DOI: 10.1126/science.289.5484.1508] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Influence of bisphosphonates on orthodontic tooth movement in mice.
Y. Fujimura, H. Kitaura, M. Yoshimatsu, T. Eguchi, H. Kohara, Y. Morita, and N. Yoshida (2009)
Eur J Orthod
|Abstract »|Full Text »|PDF »
Impaired osteoclastogenesis by staphylococcal lipoteichoic acid through Toll-like receptor 2 with partial involvement of MyD88.
J. Yang, Y. H. Ryu, C.-H. Yun, and S. H. Han (2009)
J. Leukoc. Biol.
86, 823-831
|Abstract »|Full Text »|PDF »
Ae2a,b-Deficient mice exhibit osteopetrosis of long bones but not of calvaria.
I. D. C. Jansen, P. Mardones, F. Lecanda, T. J. de Vries, S. Recalde, K. A. Hoeben, T. Schoenmaker, J.-H. Ravesloot, M. M. G. J. van Borren, T. M. van Eijden, et al. (2009)
FASEB J
23, 3470-3481
|Abstract »|Full Text »|PDF »
GM-CSF Regulates Fusion of Mononuclear Osteoclasts into Bone-Resorbing Osteoclasts by Activating the Ras/ERK Pathway.
M. S. Lee, H. S. Kim, J.-T. Yeon, S.-W. Choi, C. H. Chun, H. B. Kwak, and J. Oh (2009)
J. Immunol.
183, 3390-3399
|Abstract »|Full Text »|PDF »
IL-27 Abrogates Receptor Activator of NF-{kappa}B Ligand-Mediated Osteoclastogenesis of Human Granulocyte-Macrophage Colony-Forming Unit Cells through STAT1-Dependent Inhibition of c-Fos.
M. Furukawa, H. Takaishi, J. Takito, M. Yoda, S. Sakai, T. Hikata, A. Hakozaki, S. Uchikawa, M. Matsumoto, K. Chiba, et al. (2009)
J. Immunol.
183, 2397-2406
|Abstract »|Full Text »|PDF »
The Mechanism of Osteoclast Differentiation Induced by IL-1.
J. H. Kim, H. M. Jin, K. Kim, I. Song, B. U. Youn, K. Matsuo, and N. Kim (2009)
J. Immunol.
183, 1862-1870
|Abstract »|Full Text »|PDF »
Syk Tyrosine 317 Negatively Regulates Osteoclast Function via the Ubiquitin-Protein Isopeptide Ligase Activity of Cbl.
W. Zou, J. L. Reeve, H. Zhao, F. P. Ross, and S. L. Teitelbaum (2009)
J. Biol. Chem.
284, 18833-18839
|Abstract »|Full Text »|PDF »
Identification of LRRc17 as a Negative Regulator of Receptor Activator of NF-{kappa}B Ligand (RANKL)-induced Osteoclast Differentiation.
T. Kim, K. Kim, S. H. Lee, H.-S. So, J. Lee, N. Kim, and Y. Choi (2009)
J. Biol. Chem.
284, 15308-15316
|Abstract »|Full Text »|PDF »
Myocyte Enhancer Factor 2 and Microphthalmia-associated Transcription Factor Cooperate with NFATc1 to Transactivate the V-ATPase d2 Promoter during RANKL-induced Osteoclastogenesis.
H. Feng, T. Cheng, J. H. Steer, D. A. Joyce, N. J. Pavlos, C. Leong, J. Kular, J. Liu, X. Feng, M. H. Zheng, et al. (2009)
J. Biol. Chem.
284, 14667-14676
|Abstract »|Full Text »|PDF »
Trolox Prevents Osteoclastogenesis by Suppressing RANKL Expression and Signaling.
J.-H. Lee, H.-N. Kim, D. Yang, K. Jung, H.-M. Kim, H.-H. Kim, H. Ha, and Z. H. Lee (2009)
J. Biol. Chem.
284, 13725-13734
|Abstract »|Full Text »|PDF »
Involution of Collagen-Induced Arthritis with an Angiogenesis Inhibitor, PPI-2458.
E. Brahn, N. Schoettler, S. Lee, and M. L. Banquerigo (2009)
J. Pharmacol. Exp. Ther.
329, 615-624
|Abstract »|Full Text »|PDF »
Cross-Presentation by Osteoclasts Induces FoxP3 in CD8+ T Cells.
J. R. Kiesel, Z. S. Buchwald, and R. Aurora (2009)
J. Immunol.
182, 5477-5487
|Abstract »|Full Text »|PDF »
Molecular Mechanism of the Bifunctional Role of Lipopolysaccharide in Osteoclastogenesis.
J. Liu, S. Wang, P. Zhang, N. Said-Al-Naief, S. M. Michalek, and X. Feng (2009)
J. Biol. Chem.
284, 12512-12523
|Abstract »|Full Text »|PDF »
Regulated Proteolysis of Nonmuscle Myosin IIA Stimulates Osteoclast Fusion.
B. K. McMichael, R. B. Wysolmerski, and B. S. Lee (2009)
J. Biol. Chem.
284, 12266-12275
|Abstract »|Full Text »|PDF »
Histamine Promotes Osteoclastogenesis through the Differential Expression of Histamine Receptors on Osteoclasts and Osteoblasts.
M. Biosse-Duplan, B. Baroukh, M. Dy, M.-C. de Vernejoul, and J.-L. Saffar (2009)
Am. J. Pathol.
174, 1426-1434
|Abstract »|Full Text »|PDF »
No evidence for a bone phenotype in GPRC6A knockout mice under normal physiological conditions.
P. Wellendorph, L. D. Johansen, A. A Jensen, E. Casanova, M. Gassmann, P. Deprez, P. Clement-Lacroix, B. Bettler, and H. Brauner-Osborne (2009)
J. Mol. Endocrinol.
42, 215-223
|Abstract »|Full Text »|PDF »
Bone Marrow Monocyte PECAM-1 Deficiency Elicits Increased Osteoclastogenesis Resulting in Trabecular Bone Loss.
Y. Wu, K. Tworkoski, M. Michaud, and J. A. Madri (2009)
J. Immunol.
182, 2672-2679
|Abstract »|Full Text »|PDF »
Calcium Metabolism in the Early Posttransplantation Period.
P. Evenepoel, B. Van Den Bergh, M. Naesens, H. De Jonge, B. Bammens, K. Claes, D. Kuypers, and Y. Vanrenterghem (2009)
Clin. J. Am. Soc. Nephrol.
4, 665-672
|Abstract »|Full Text »|PDF »
The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo.
H.-J. Kim, K. Zhang, L. Zhang, F. P. Ross, S. L. Teitelbaum, and R. Faccio (2009)
PNAS
106, 2325-2330
|Abstract »|Full Text »|PDF »
Mutations within the TNF-Like Core Domain of RANKL Impair Osteoclast Differentiation and Activation.
T. Cheng, N. J. Pavlos, C. Wang, J. W.-Y. Tan, J. M. Lin, J. Cornish, M.-H. Zheng, and J. Xu (2009)
Mol. Endocrinol.
23, 35-46
|Abstract »|Full Text »|PDF »
Altered TNSALP Expression and Phosphate Regulation Contribute to Reduced Mineralization in Mice Lacking Androgen Receptor.
H.-Y. Kang, C.-R. Shyr, C.-K. Huang, M.-Y. Tsai, H. Orimo, P.-C. Lin, C. Chang, and K.-E. Huang (2008)
Mol. Cell. Biol.
28, 7354-7367
|Abstract »|Full Text »|PDF »
Sevelamer Restores Bone Volume and Improves Bone Microarchitecture and Strength in Aged Ovariectomized Rats.
T. K. Sampath, P. Simic, S. Moreno, N. Bukanov, N. Draca, V. Kufner, A. Tikvica, A. Blair, D. Semenski, M. Brncic, et al. (2008)
Endocrinology
149, 6092-6102
|Abstract »|Full Text »|PDF »
Lowering Bone Mineral Affinity of Bisphosphonates as a Therapeutic Strategy to Optimize Skeletal Tumor Growth Inhibition In vivo.
P. G.J. Fournier, F. Daubine, M. W. Lundy, M. J. Rogers, F. H. Ebetino, and P. Clezardin (2008)
Cancer Res.
68, 8945-8953
|Abstract »|Full Text »|PDF »
The Association of Notch2 and NF-{kappa}B Accelerates RANKL-Induced Osteoclastogenesis.
H. Fukushima, A. Nakao, F. Okamoto, M. Shin, H. Kajiya, S. Sakano, A. Bigas, E. Jimi, and K. Okabe (2008)
Mol. Cell. Biol.
28, 6402-6412
|Abstract »|Full Text »|PDF »
Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference.
R. E. Coleman, T. A. Guise, A. Lipton, G. D. Roodman, J. R. Berenson, J.-J. Body, B. F. Boyce, L. M. Calvi, P. Hadji, E. V. McCloskey, et al. (2008)
Clin. Cancer Res.
14, 6387-6395
|Abstract »|Full Text »|PDF »
Inhibitory Immunoglobulin-Like Receptors LILRB and PIR-B Negatively Regulate Osteoclast Development.
Y. Mori, S. Tsuji, M. Inui, Y. Sakamoto, S. Endo, Y. Ito, S. Fujimura, T. Koga, A. Nakamura, H. Takayanagi, et al. (2008)
J. Immunol.
181, 4742-4751
|Abstract »|Full Text »|PDF »
Osteoimmunology: Interactions of the Bone and Immune System.
Cytoplasmic Terminus of Vacuolar Type Proton Pump Accessory Subunit Ac45 Is Required for Proper Interaction with V0 Domain Subunits and Efficient Osteoclastic Bone Resorption.
H. Feng, T. Cheng, N. J. Pavlos, K. H. M. Yip, A. Carrello, R. Seeber, K. Eidne, M. H. Zheng, and J. Xu (2008)
J. Biol. Chem.
283, 13194-13204
|Abstract »|Full Text »|PDF »
Gut, inflammation and osteoporosis: basic and clinical concepts.
An Enhancer 20 Kilobases Upstream of the Human Receptor Activator of Nuclear Factor-{kappa}B Ligand Gene Mediates Dominant Activation by 1,25-Dihydroxyvitamin D3.
R. D. Nerenz, M. L. Martowicz, and J. W. Pike (2008)
Mol. Endocrinol.
22, 1044-1056
|Abstract »|Full Text »|PDF »
Osteoprotegerin Lys3Asn Polymorphism and the Risk of Fracture in Older Women.
S. P. Moffett, J. I. Oakley, J. A. Cauley, L. Y. Lui, K. E. Ensrud, B. C. Taylor, T. A. Hillier, M. C. Hochberg, J. Li, S. Cayabyab, et al. (2008)
J. Clin. Endocrinol. Metab.
93, 2002-2008
|Abstract »|Full Text »|PDF »
Inhibition of osteoclasts does not prevent joint ankylosis in a mouse model of spondyloarthritis.
R. J. U. Lories, I. Derese, and F. P. Luyten (2008)
Rheumatology
47, 605-608
|Abstract »|Full Text »|PDF »
The Tec Family Tyrosine Kinase Btk Regulates RANKL-induced Osteoclast Maturation.
S. H. Lee, T. Kim, D. Jeong, N. Kim, and Y. Choi (2008)
J. Biol. Chem.
283, 11526-11534
|Abstract »|Full Text »|PDF »
An Anti-c-Fms Antibody Inhibits Orthodontic Tooth Movement.
H. Kitaura, M. Yoshimatsu, Y. Fujimura, T. Eguchi, H. Kohara, A. Yamaguchi, and N. Yoshida (2008)
Journal of Dental Research
87, 396-400
|Abstract »|Full Text »|PDF »
Tumor Necrosis Factor-{alpha}-converting Enzyme (TACE) Levels in Periodontal Diseases.
N. Bostanci, G. Emingil, B. Afacan, B. Han, T. Ilgenli, G. Atilla, F.J. Hughes, and G.N. Belibasakis (2008)
Journal of Dental Research
87, 273-277
|Abstract »|Full Text »|PDF »
The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis.
A P Anandarajah, E M Schwarz, S Totterman, J Monu, C Y Feng, T Shao, S A Haas-Smith, and C T Ritchlin (2008)
Ann Rheum Dis
67, 296-301
|Abstract »|Full Text »|PDF »
The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon- induced inhibitory signaling.
Y. Lee, S.-W. Hyung, H. J. Jung, H.-J. Kim, J. Staerk, S. N. Constantinescu, E.-J. Chang, Z. H. Lee, S.-W. Lee, and H.-H. Kim (2008)
Blood
111, 885-893
|Abstract »|Full Text »|PDF »
NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP).
K. Kim, S.-H. Lee, J. Ha Kim, Y. Choi, and N. Kim (2008)
Mol. Endocrinol.
22, 176-185
|Abstract »|Full Text »|PDF »
Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression.
F. C. Mansergh, T. Wells, C. Elford, S. L. Evans, M. J. Perry, M. J. Evans, and B. A. J. Evans (2007)
Physiol Genomics
32, 64-73
|Abstract »|Full Text »|PDF »
Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-{kappa}B and c-Fms.
S. Granholm, P. Lundberg, and U. H Lerner (2007)
J. Endocrinol.
195, 415-427
|Abstract »|Full Text »|PDF »
Conditional Disruption of Calcineurin B1 in Osteoblasts Increases Bone Formation and Reduces Bone Resorption.
H. Yeo, L. H. Beck, S. R. Thompson, M. C. Farach-Carson, J. M. McDonald, T. L. Clemens, and M. Zayzafoon (2007)
J. Biol. Chem.
282, 35318-35327
|Abstract »|Full Text »|PDF »
A Cathepsin K Inhibitor Reduces Breast Cancer Induced Osteolysis and Skeletal Tumor Burden.
C. Le Gall, A. Bellahcene, E. Bonnelye, J. A. Gasser, V. Castronovo, J. Green, J. Zimmermann, and P. Clezardin (2007)
Cancer Res.
67, 9894-9902
|Abstract »|Full Text »|PDF »
6-Methylprednisolone down-regulates IRAK-M in human and murine osteoclasts and boosts bone-resorbing activity: a putative mechanism for corticoid-induced osteoporosis.
A. Soares-Schanoski, V. Gomez-Pina, C. del Fresno, A. Rodriguez-Rojas, F. Garcia, A. Glaria, M. Sanchez, M. T. Vallejo-Cremades, R. Baos, P. Fuentes-Prior, et al. (2007)
J. Leukoc. Biol.
82, 700-709
|Abstract »|Full Text »|PDF »
Conversations Between Breast and Bone: Physiological Bone Loss During Lactation as Evolutionary Template for Osteolysis in Breast Cancer and Pathological Bone Loss After Menopause.
Weaning Triggers a Decrease in Receptor Activator of Nuclear Factor-{kappa}B Ligand Expression, Widespread Osteoclast Apoptosis, and Rapid Recovery of Bone Mass after Lactation in Mice.
L. Ardeshirpour, P. Dann, D. J. Adams, T. Nelson, J. VanHouten, M. C. Horowitz, and J. J. Wysolmerski (2007)
Endocrinology
148, 3875-3886
|Abstract »|Full Text »|PDF »
Tumor {alpha}v{beta}3 Integrin Is a Therapeutic Target for Breast Cancer Bone Metastases.
Y. Zhao, R. Bachelier, I. Treilleux, P. Pujuguet, O. Peyruchaud, R. Baron, P. Clement-Lacroix, and P. Clezardin (2007)
Cancer Res.
67, 5821-5830
|Abstract »|Full Text »|PDF »
Nuclear Factor {kappa}B p65 Phosphorylation in Orthodontic Tooth Movement.
J. Zuo, L.A. Archer, A. Cooper, K.L. Johnson, L.S. Holliday, and C. Dolce (2007)
Journal of Dental Research
86, 556-559
|Abstract »|Full Text »|PDF »
Osteopontin is required for mechanical stress-dependent signals to bone marrow cells.
M. Ishijima, K. Tsuji, S. R Rittling, T. Yamashita, H. Kurosawa, D. T Denhardt, A. Nifuji, Y. Ezura, and M. Noda (2007)
J. Endocrinol.
193, 235-243
|Abstract »|Full Text »|PDF »
Protein Inhibitor of Activated STAT 3 Modulates Osteoclastogenesis by Down-Regulation of NFATc1 and Osteoclast-Associated Receptor.
K. Kim, J. Lee, J. H. Kim, H. M. Jin, B. Zhou, S. Y. Lee, and N. Kim (2007)
J. Immunol.
178, 5588-5594
|Abstract »|Full Text »|PDF »
B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo.
Y. Li, G. Toraldo, A. Li, X. Yang, H. Zhang, W.-P. Qian, and M. N. Weitzmann (2007)
Blood
109, 3839-3848
|Abstract »|Full Text »|PDF »
K. Kim, J. H. Kim, J. Lee, H. M. Jin, H. Kook, K. K. Kim, S. Y. Lee, and N. Kim (2007)
Blood
109, 3253-3259
|Abstract »|Full Text »|PDF »
15-Deoxy-{Delta}12,14-Prostaglandin J2 Negatively Regulates rankl Gene Expression in Activated T Lymphocytes: Role of NF-{kappa}B and Early Growth Response Transcription Factors.
C. Fionda, F. Nappi, M. Piccoli, L. Frati, A. Santoni, and M. Cippitelli (2007)
J. Immunol.
178, 4039-4050
|Abstract »|Full Text »|PDF »
Attenuation of Bone Mass and Increase of Osteoclast Formation in Decoy Receptor 3 Transgenic Mice.
C.-H. Tang, T.-L. Hsu, W.-W. Lin, M.-Z. Lai, R.-S. Yang, S.-L. Hsieh, and W.-M. Fu (2007)
J. Biol. Chem.
282, 2346-2354
|Abstract »|Full Text »|PDF »
Transcriptional Control of Receptor Activator of Nuclear Factor-{kappa}B Ligand by the Protein Kinase A Activator Forskolin and the Transmembrane Glycoprotein 130-Activating Cytokine, Oncostatin M, Is Exerted through Multiple Distal Enhancers.
S. Kim, M. Yamazaki, N. K. Shevde, and J. W. Pike (2007)
Mol. Endocrinol.
21, 197-214
|Abstract »|Full Text »|PDF »
Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.
E.-J. Chang, H. J. Kim, J. Ha, H. J. Kim, J. Ryu, K.-H. Park, U.-H. Kim, Z. H. Lee, H.-M. Kim, D. E. Fisher, et al. (2007)
J. Cell Sci.
120, 166-176
|Abstract »|Full Text »|PDF »
Association of leupaxin with Src in osteoclasts.
S. N. Sahu, M. A. Khadeer, B. W. Robertson, S. M. Nunez, G. Bai, and A. Gupta (2007)
Am J Physiol Cell Physiol
292, C581-C590
|Abstract »|Full Text »|PDF »
Unique uptake and efflux systems of inorganic phosphate in osteoclast-like cells.
M. Ito, S. Haito, M. Furumoto, Y. Uehata, A. Sakurai, H. Segawa, S. Tatsumi, M. Kuwahata, and K.-i. Miyamoto (2007)
Am J Physiol Cell Physiol
292, C526-C534
|Abstract »|Full Text »|PDF »
High-Sensitivity C-Reactive Protein and Risk of Nontraumatic Fractures in the Bruneck Study.
G. Schett, S. Kiechl, S. Weger, A. Pederiva, A. Mayr, M. Petrangeli, F. Oberhollenzer, R. Lorenzini, K. Redlich, R. Axmann, et al. (2006)
Arch Intern Med
166, 2495-2501
|Abstract »|Full Text »|PDF »
Estradiol Protects against Ethanol-Induced Bone Loss by Inhibiting Up-Regulation of Receptor Activator of Nuclear Factor-{kappa}B Ligand in Osteoblasts.
J.-R. Chen, R. L. Haley, M. Hidestrand, K. Shankar, X. Liu, C. K. Lumpkin, P. M. Simpson, T. M. Badger, and M. J. J. Ronis (2006)
J. Pharmacol. Exp. Ther.
319, 1182-1190
|Abstract »|Full Text »|PDF »
Involvement of the Src-cortactin pathway in podosome formation and turnover during polarization of cultured osteoclasts.
C. Luxenburg, J. T. Parsons, L. Addadi, and B. Geiger (2006)
J. Cell Sci.
119, 4878-4888
|Abstract »|Full Text »|PDF »
Age-dependent alterations in Ca2+ homeostasis: role of TRPV5 and TRPV6.
M. van Abel, S. Huybers, J. G. J. Hoenderop, A. W. C. M. van der Kemp, J. P. T. M. van Leeuwen, and R. J. M. Bindels (2006)
Am J Physiol Renal Physiol
291, F1177-F1183
|Abstract »|Full Text »|PDF »
c-Src Control of Chloride Channel Support for Osteoclast HCl Transport and Bone Resorption.
J. C. Edwards, C. Cohen, W. Xu, and P. H. Schlesinger (2006)
J. Biol. Chem.
281, 28011-28022
|Abstract »|Full Text »|PDF »
Activation of Receptor Activator of NF-{kappa}B Ligand Gene Expression by 1,25-Dihydroxyvitamin D3 Is Mediated through Multiple Long-Range Enhancers..
S. Kim, M. Yamazaki, L. A. Zella, N. K. Shevde, and J. W. Pike (2006)
Mol. Cell. Biol.
26, 6469-6486
|Abstract »|Full Text »|PDF »
B and T Lymphocytes Are the Primary Sources of RANKL in the Bone Resorptive Lesion of Periodontal Disease.
T. Kawai, T. Matsuyama, Y. Hosokawa, S. Makihira, M. Seki, N. Y. Karimbux, R. B. Goncalves, P. Valverde, S. Dibart, Y.-P. Li, et al. (2006)
Am. J. Pathol.
169, 987-998
|Abstract »|Full Text »|PDF »
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
M. M. Rahman, A. Bhattacharya, and G. Fernandes (2006)
J. Lipid Res.
47, 1739-1748
|Abstract »|Full Text »|PDF »
Involvement of Aquaporin 9 in Osteoclast Differentiation.
Nrf2 Negatively Regulates Osteoblast Differentiation via Interfering with Runx2-dependent Transcriptional Activation.
E. Hinoi, S. Fujimori, L. Wang, H. Hojo, K. Uno, and Y. Yoneda (2006)
J. Biol. Chem.
281, 18015-18024
|Abstract »|Full Text »|PDF »
The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.
A. Boucharaba, C.-M. Serre, J. Guglielmi, J.-C. Bordet, P. Clezardin, and O. Peyruchaud (2006)
PNAS
103, 9643-9648
|Abstract »|Full Text »|PDF »
Altered bone and mineral metabolism in patients receiving imatinib mesylate..
E. Berman, M. Nicolaides, R. G. Maki, M. Fleisher, S. Chanel, K. Scheu, B.-A. Wilson, G. Heller, and N. P. Sauter (2006)
N. Engl. J. Med.
354, 2006-2013
|Abstract »|Full Text »|PDF »
1'-Acetoxychavicol Acetate Inhibits RANKL-Induced Osteoclastic Differentiation of RAW 264.7 Monocytic Cells by Suppressing Nuclear Factor-{kappa}B Activation.
H. Ichikawa, A. Murakami, and B. B. Aggarwal (2006)
Mol. Cancer Res.
4, 275-281
|Abstract »|Full Text »|PDF »
Murine Osteoclast Formation and Function: Differential Regulation by Humoral Agents.
K. Fuller, B. Kirstein, and T. J. Chambers (2006)
Endocrinology
147, 1979-1985
|Abstract »|Full Text »|PDF »
Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation.
J. Lee, K. Kim, J. H. Kim, H. M. Jin, H. K. Choi, S.-H. Lee, H. Kook, K. K. Kim, Y. Yokota, S. Y. Lee, et al. (2006)
Blood
107, 2686-2693
|Abstract »|Full Text »|PDF »
Non-cytotoxic Cobra Cardiotoxin A5 Binds to {alpha}vbeta3 Integrin and Inhibits Bone Resorption: IDENTIFICATION OF CARDIOTOXINS AS NON-RGD INTEGRIN-BINDING PROTEINS OF THE Ly-6 FAMILY.
P.-L. Wu, S.-C. Lee, C.-C. Chuang, S. Mori, N. Akakura, W.-g. Wu, and Y. Takada (2006)
J. Biol. Chem.
281, 7937-7945
|Abstract »|Full Text »|PDF »
Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.
J.-T. Woo, M. Kawatani, M. Kato, T. Shinki, T. Yonezawa, N. Kanoh, H. Nakagawa, M. Takami, K. H. Lee, P. H. Stern, et al. (2006)
PNAS
103, 4729-4734
|Abstract »|Full Text »|PDF »
A Novel Receptor Activator of NF-{kappa}B (RANK) Cytoplasmic Motif Plays an Essential Role in Osteoclastogenesis by Committing Macrophages to the Osteoclast Lineage.
D. Xu, S. Wang, W. Liu, J. Liu, and X. Feng (2006)
J. Biol. Chem.
281, 4678-4690
|Abstract »|Full Text »|PDF »
Inhibition of Hormone and Cytokine-stimulated Osteoclastogenesis and Bone Resorption by Interleukin-4 and Interleukin-13 Is Associated with Increased Osteoprotegerin and Decreased RANKL and RANK in a STAT6-dependent Pathway.
P. Palmqvist, P. Lundberg, E. Persson, A. Johansson, I. Lundgren, A. Lie, H. H. Conaway, and U. H. Lerner (2006)
J. Biol. Chem.
281, 2414-2429
|Abstract »|Full Text »|PDF »
Guggulsterone Inhibits Osteoclastogenesis Induced by Receptor Activator of Nuclear Factor-{kappa}B Ligand and by Tumor Cells by Suppressing Nuclear Factor-{kappa}B Activation.
Receptor Activator of NF-{kappa}B (RANK) Cytoplasmic Motif, 369PFQEP373, Plays a Predominant Role in Osteoclast Survival in Part by Activating Akt/PKB and Its Downstream Effector AFX/FOXO4.
W. Liu, S. Wang, S. Wei, L. Sun, and X. Feng (2005)
J. Biol. Chem.
280, 43064-43072
|Abstract »|Full Text »|PDF »
Osteoclastogenic Activity during Mandibular Distraction Osteogenesis.
L.C. Wang, I. Takahashi, Y. Sasano, J. Sugawara, and H. Mitani (2005)
Journal of Dental Research
84, 1010-1015
|Abstract »|Full Text »|PDF »
Cells of the Osteoclast Lineage as Mediators of the Anabolic Actions of Parathyroid Hormone in Bone.
A. J. Koh, B. Demiralp, K. G. Neiva, J. Hooten, R. M. Nohutcu, H. Shim, N. S. Datta, R. S. Taichman, and L. K. McCauley (2005)
Endocrinology
146, 4584-4596
|Abstract »|Full Text »|PDF »
Nuclear Factor of Activated T Cells c1 Induces Osteoclast-associated Receptor Gene Expression during Tumor Necrosis Factor-related Activation-induced Cytokine-mediated Osteoclastogenesis.
K. Kim, J. H. Kim, J. Lee, H.-M. Jin, S.-H. Lee, D. E. Fisher, H. Kook, K. K. Kim, Y. Choi, and N. Kim (2005)
J. Biol. Chem.
280, 35209-35216
|Abstract »|Full Text »|PDF »
Transforming Growth Factor-{beta}1 to the Bone.
K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul (2005)
Endocr. Rev.
26, 743-774
|Abstract »|Full Text »|PDF »
Physical and Functional Association of c-Src and Adhesion and Degranulation Promoting Adaptor Protein (ADAP) in Osteoclastogenesis in Vitro.
S. Koga, K. Yogo, K. Yoshikawa, H. Samori, M. Goto, T. Uchida, N. Ishida, and T. Takeya (2005)
J. Biol. Chem.
280, 31564-31571
|Abstract »|Full Text »|PDF »
Osthole-Mediated Cell Differentiation through Bone Morphogenetic Protein-2/p38 and Extracellular Signal-Regulated Kinase 1/2 Pathway in Human Osteoblast Cells.
P.-L. Kuo, Y.-L. Hsu, C.-H. Chang, and J.-K. Chang (2005)
J. Pharmacol. Exp. Ther.
314, 1290-1299
|Abstract »|Full Text »|PDF »
{micro}-Calpain Regulates Receptor Activator of NF-{kappa}B Ligand (RANKL)-supported Osteoclastogenesis via NF-{kappa}B Activation in RAW 264.7 Cells.
F. Y.-I. Lee, D.-W. Kim, J. A. Karmin, D. Hong, S.-S. Chang, M. Fujisawa, H. Takayanagi, L. U. Bigliani, T. A. Blaine, and H.-J. Lee (2005)
J. Biol. Chem.
280, 29929-29936
|Abstract »|Full Text »|PDF »
Bisphosphonates in Orthopaedic Surgery.
C. D. Morris and T. A. Einhorn (2005)
J. Bone Joint Surg. Am.
87, 1609-1618
|Abstract »|Full Text »|PDF »
Homeostatic Role of Interferons Conferred by Inhibition of IL-1-Mediated Inflammation and Tissue Destruction.
X. Hu, H. H. Ho, O. Lou, C. Hidaka, and L. B. Ivashkiv (2005)
J. Immunol.
175, 131-138
|Abstract »|Full Text »|PDF »
Rab3D Regulates a Novel Vesicular Trafficking Pathway That Is Required for Osteoclastic Bone Resorption.
N. J. Pavlos, J. Xu, D. Riedel, J. S. G. Yeoh, S. L. Teitelbaum, J. M. Papadimitriou, R. Jahn, F. P. Ross, and M. H. Zheng (2005)
Mol. Cell. Biol.
25, 5253-5269
|Abstract »|Full Text »|PDF »
Potassium Channel-blockers as Therapeutic Agents to Interfere with Bone Resorption of Periodontal Disease.
P. Valverde, T. Kawai, and M.A. Taubman (2005)
Journal of Dental Research
84, 488-499
|Abstract »|Full Text »|PDF »
Evolution and modulation of age-related medial elastocalcinosis: Impact on large artery stiffness and isolated systolic hypertension.
H. H. Dao, R. Essalihi, C. Bouvet, and P. Moreau (2005)
Cardiovasc Res
66, 307-317
|Abstract »|Full Text »|PDF »
Reactive Oxygen Species Stimulates Receptor Activator of NF-{kappa}B Ligand Expression in Osteoblast.
X.-c. Bai, D. Lu, A.-l. Liu, Z.-m. Zhang, X.-m. Li, Z.-p. Zou, W.-s. Zeng, B.-l. Cheng, and S.-q. Luo (2005)
J. Biol. Chem.
280, 17497-17506
|Abstract »|Full Text »|PDF »
Osteoporosis and Integrins.
S. L. Teitelbaum (2005)
J. Clin. Endocrinol. Metab.
90, 2466-2468
|Full Text »|PDF »
Effect of L-000845704, an {alpha}V{beta}3 Integrin Antagonist, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic Women.
M. G. Murphy, K. Cerchio, S. A. Stoch, K. Gottesdiener, M. Wu, R. Recker, and for the L-000845704 Study Group (2005)
J. Clin. Endocrinol. Metab.
90, 2022-2028
|Abstract »|Full Text »|PDF »
Interleukin-3 and Granulocyte-Macrophage Colony-stimulating Factor Inhibits Tumor Necrosis Factor (TNF)-{alpha}-induced Osteoclast Differentiation by Down-regulation of Expression of TNF Receptors 1 and 2.
S. D. Yogesha, S. M. Khapli, and M. R. Wani (2005)
J. Biol. Chem.
280, 11759-11769
|Abstract »|Full Text »|PDF »
CD44 is a determinant of inflammatory bone loss.
S. Hayer, G. Steiner, B. Gortz, E. Reiter, M. Tohidast-Akrad, M. Amling, O. Hoffmann, K. Redlich, J. Zwerina, K. Skriner, et al. (2005)
J. Exp. Med.
201, 903-914
|Abstract »|Full Text »|PDF »
